SENS logo

SENS Senseonics Holdings, Inc.

NASDAQ Global Select · Medical - Devices · Healthcare

$10.58
+0.54 (+5.38%)

Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices…

Market Cap: $579.58Mwww.senseonics.com

Price

No data yet.

Social Signal Score

55
5d
—
30d
55
6 mentions
—
60d
55
8 mentions
—
90d
55
11 mentions
—
news: 11

Analyst Ratings

17 analysts
Buyconsensus
Strong Buy 0Buy 8Hold 7Sell 2Strong Sell 0
Avg price target$15+41.8%
Low $10Median $15High $20
Current Consensus

Revenue

$19.56M+6987.32%
$36.0K$6.54M$13.05M$19.56M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-1.46
$-1.49–$-1.44
5 analysts
FY2026
$-2.20
$-2.35–$-2.14
6 analysts
FY2027
$-1.85
$-2.18–$-1.69
6 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Timothy T. Goodnow
Sector
Healthcare
Industry
Medical - Devices
Employees
130
Beta
1.04
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-6.63
www.senseonics.com